| Akums Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544222 |
NSE Symbol : AKUMS |
P/E(TTM) : 103.97 |
|
ISIN Demat : INE09XN01023 |
Div & Yield% : 0.38 |
EPS(TTM) : 7.40 |
|
Book Value(₹) : 154.29 |
Market Cap(₹Cr) : 12,109.11 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 392.28 | 338.37 | 368.61 | 309.32 | 332.44 | 328.75 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 392.28 | 338.37 | 368.61 | 309.32 | 332.44 | 328.75 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 26.10 | 27.73 | 29.60 | 27.08 | 28.56 | 32.05 |
| Total Income | 418.38 | 366.10 | 398.21 | 336.39 | 361.00 | 360.80 |
| Total Expenditure | 343.77 | 329.30 | 347.74 | 292.42 | 288.34 | 311.03 |
| PBIDT | 74.61 | 36.81 | 50.47 | 43.97 | 72.66 | 49.77 |
| Interest | 2.48 | 2.59 | 2.46 | 2.08 | 2.91 | 2.63 |
| PBDT | 72.13 | 34.21 | 48.01 | 41.89 | 69.75 | 47.15 |
| Depreciation | 12.80 | 12.42 | 12.15 | 10.69 | 10.25 | 10.09 |
| Tax | 15.35 | 3.27 | 8.60 | 8.31 | 16.22 | 8.26 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.85 | 3.33 | -0.85 | -0.57 | -1.58 | 1.21 |
| Reported Profit After Tax | 44.84 | 15.20 | 28.11 | 23.46 | 44.87 | 27.59 |
| Extra-ordinary Items | 0.00 | -1.89 | -2.90 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 44.84 | 17.09 | 31.01 | 23.46 | 44.87 | 27.59 |
| EPS (Unit Curr.) | 2.93 | 0.99 | 1.84 | 1.53 | 2.93 | 1.80 |
| EPS (Adj) (Unit Curr.) | 2.93 | 0.99 | 1.84 | 1.53 | 2.93 | 1.80 |
| Calculated EPS (Unit Curr.) | 2.93 | 0.99 | 1.84 | 1.53 | 2.93 | 1.80 |
| Calculated EPS (Adj) (Unit Curr.) | 2.93 | 0.99 | 1.84 | 1.53 | 2.93 | 1.80 |
| Calculated EPS (Ann.) (Unit Curr.) | 11.71 | 3.97 | 7.35 | 6.13 | 11.72 | 7.21 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 11.71 | 3.97 | 7.35 | 6.13 | 11.72 | 7.21 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 30.62 | 30.62 | 30.62 | 30.62 | 30.62 | 30.62 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 19.02 | 10.88 | 13.69 | 14.22 | 21.86 | 15.14 |
| PBDTM(%) | 18.39 | 10.11 | 13.02 | 13.54 | 20.98 | 14.34 |
| PATM(%) | 11.43 | 4.49 | 7.63 | 7.58 | 13.50 | 8.39 |
